AIDS-Related Lymphoma

We draw upon more than 30 years of experience in managing AIDS-related lymphoma, which can develop in people with untreated or advanced HIV. Our specialists use sophisticated diagnostic tools to develop personalized treatment plans for this cancer, which arises in white blood cells called lymphocytes. Treatments can include chemotherapy, targeted drugs, stem cell transplantation, or radiation therapy, combined with antiretroviral therapy. We can also determine whether new therapies offered through a clinical trial may be right for you.

Clinical Trials and Research Studies

Phase 3

A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Na ve Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel Genomic Biomarker DGM1

Phase 1/2

A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

Phase 1

A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621 a Novel Biologic Targeting CD47 in Subjects with Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors

Phase 1/2

AN OPEN-LABEL MULTICENTER PHASE l/1B TRIAL EVALUATING THE SAFETY ANDPHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A AS A SINGLE AGENT ANDCOMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORYB-CELL NON-HODGKIN S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA